The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126107602 12610760 2 F 20160801 20160801 20160803 EXP JP-JNJFOC-20160718811 JANSSEN IIOKA F, IZUMI K, KAMODA Y, AKASAKA T, OHNO H. OUTCOMES OF VERY ELDERLY PATIENTS WITH AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA TREATED WITH REDUCED-DOSE CHEMOTHERAPY. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 01-JUN-2016;21 (3):498-505. 0.00 E Y 0.00000 20160803 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126107602 12610760 1 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) R-VCHOP N 0 50 MG/M**2 LIPOSOME INJECTION
126107602 12610760 2 PS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) R-MINICHOP N 50718 25 MG/M**2 LIPOSOME INJECTION
126107602 12610760 3 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) R-MINICHOP 0 25 MG/M**2 LIPOSOME INJECTION
126107602 12610760 4 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) R-VCHOP 0 50 MG/M**2 LIPOSOME INJECTION
126107602 12610760 5 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown R-VCHOP 0 750 MG/M**2 UNSPECIFIED
126107602 12610760 6 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown R-MINICHOP 0 400 MG/M**2 UNSPECIFIED
126107602 12610760 7 SS VINCRISTINE VINCRISTINE 1 Unknown R-MINICHOP 0 1 MG UNSPECIFIED
126107602 12610760 8 SS VINCRISTINE VINCRISTINE 1 Unknown R-VCHOP 0 1.4 MG/M**2 UNSPECIFIED
126107602 12610760 9 SS PREDNISOLONE. PREDNISOLONE 1 Unknown R-VCHOP 0 100 MG UNSPECIFIED
126107602 12610760 10 SS PREDNISOLONE. PREDNISOLONE 1 Unknown R-MINICHOP 0 40 MG/M**2 UNSPECIFIED
126107602 12610760 11 SS RITUXIMAB RITUXIMAB 1 Unknown R-VCHOP 0 375 MG/M**2 UNSPECIFIED
126107602 12610760 12 SS RITUXIMAB RITUXIMAB 1 Unknown R-MINICHOP 0 375 MG/M**2 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126107602 12610760 1 B-cell lymphoma
126107602 12610760 2 B-cell lymphoma
126107602 12610760 3 B-cell lymphoma
126107602 12610760 4 B-cell lymphoma
126107602 12610760 5 B-cell lymphoma
126107602 12610760 6 B-cell lymphoma
126107602 12610760 7 B-cell lymphoma
126107602 12610760 8 B-cell lymphoma
126107602 12610760 9 B-cell lymphoma
126107602 12610760 10 B-cell lymphoma
126107602 12610760 11 B-cell lymphoma
126107602 12610760 12 B-cell lymphoma

Outcome of event

Event ID CASEID OUTC COD
126107602 12610760 OT
126107602 12610760 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126107602 12610760 Anaemia
126107602 12610760 Drug intolerance
126107602 12610760 Febrile neutropenia
126107602 12610760 Hospitalisation
126107602 12610760 Ileus
126107602 12610760 Neutropenia
126107602 12610760 Off label use
126107602 12610760 Pneumonitis
126107602 12610760 Prescribed underdose
126107602 12610760 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found